These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21357523)

  • 21. [Application of perfusion CT scan in assessing the treatment and predicting prognosis for lung cancer before and after chemotherapy/radiotherapy].
    Wang JW; Wu N; Song Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):54-7. PubMed ID: 19538871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
    Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV
    AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomography.
    Knollmann FD; Kumthekar R; Fetzer D; Socinski MA
    Clin Lung Cancer; 2014 Mar; 15(2):103-9. PubMed ID: 24361250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV; Holalkere NS; Mueller PR; Zhu AX
    Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).
    Jiang T; Kambadakone A; Kulkarni NM; Zhu AX; Sahani DV
    Invest Radiol; 2012 Jan; 47(1):11-7. PubMed ID: 21512396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semiautomatic Analysis on Computed Tomography in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Unidimensional and 3-dimensional Measurements.
    Colombi D; Manna C; Montermini I; Seletti V; Diciotti S; Tiseo M; Fontana E; De Filippo M; Silva M; Sverzellati N
    J Thorac Imaging; 2015 Sep; 30(5):290-9. PubMed ID: 25837590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography.
    Ng QS; Goh V
    J Thorac Imaging; 2010 May; 25(2):142-50. PubMed ID: 20463533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.
    Sahani DV; Kalva SP; Hamberg LM; Hahn PF; Willett CG; Saini S; Mueller PR; Lee TY
    Radiology; 2005 Mar; 234(3):785-92. PubMed ID: 15734934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First pass dual input volume CT-perfusion of lung lesions: The influence of the CT- value range settings on the perfusion values of benign and malignant entities.
    Bohlsen D; Talakic E; Fritz GA; Quehenberger F; Tillich M; Schoellnast H
    Eur J Radiol; 2016 Jun; 85(6):1109-14. PubMed ID: 27161059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis.
    Yip C; Tacelli N; Remy-Jardin M; Scherpereel A; Cortot A; Lafitte JJ; Wallyn F; Remy J; Bassett P; Siddique M; Cook GJ; Landau DB; Goh V
    J Thorac Imaging; 2015 Sep; 30(5):300-7. PubMed ID: 26164165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of scan time on perfusion and flow extraction product (K-trans) measurements in lung cancer using low-dose volume perfusion CT (VPCT).
    Spira D; Gerlach JD; Spira SM; Schulze M; Sauter A; Horger M
    Acad Radiol; 2012 Jan; 19(1):78-83. PubMed ID: 22054806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluating the short-term effect of gefitinib in advanced lung adenocarcinoma with positive EGFR-mutant by dual source volume perfusion CT].
    Xiong Z; Hu CP; Liu JK; Lu RL; Zhou H; Zhou ML; Chen W
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2824-7. PubMed ID: 22333542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
    Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
    J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of CT perfusion imaging to the histological differentiation of adrenal gland tumors.
    Qin HY; Sun HR; Li YJ; Shen BZ
    Eur J Radiol; 2012 Mar; 81(3):502-7. PubMed ID: 21306850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.
    Frampas E; Lassau N; Zappa M; Vullierme MP; Koscielny S; Vilgrain V
    Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfusion CT vascular parameters do not correlate with immunohistochemically derived microvessel density count in colorectal tumors.
    Dighe S; Blake H; Jeyadevan N; Castellano I; Koh DM; Orton M; Chandler I; Swift I; Brown G
    Radiology; 2013 Aug; 268(2):400-10. PubMed ID: 23592771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density.
    Kim JW; Jeong YY; Chang NK; Heo SH; Shin SS; Lee JH; Hur YH; Kang HK
    Korean J Radiol; 2012; 13 Suppl 1(Suppl 1):S89-97. PubMed ID: 22563293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of lung tumor response by perfusion CT.
    Coche E
    JBR-BTR; 2013; 96(3):172-4. PubMed ID: 23971175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.
    Chung WS; Park MS; Shin SJ; Baek SE; Kim YE; Choi JY; Kim MJ
    AJR Am J Roentgenol; 2012 Oct; 199(4):809-15. PubMed ID: 22997372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results.
    Bisdas S; Baghi M; Wagenblast J; Knecht R; Thng CH; Koh TS; Vogl TJ
    Eur J Radiol; 2007 Nov; 64(2):258-65. PubMed ID: 17399933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.